insights_auto
Why is MYGN up 2.89%?
Dive Deeperchevron_right
MYGN:NASDAQ
Myriad Genetics Inc
$4.10
arrow_upward
+2.89%(+0.11) 1D
Oct 19, 11:36:58 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
$4.01
High
$4.10
Low
$3.95
Mkt. cap
391.69M
Avg. vol.
2.00M
Volume
182.40K
52-wk high
$8.50
52-wk low
$2.74
EPS
-$1.20
Beta
1.64
Shares outstanding
95.65M
No. of employees
3K
Open
$4.01
High
$4.10
Low
$3.95
Mkt. cap
391.69M
Avg. vol.
2.00M
Volume
182.40K
52-wk high
$8.50
52-wk low
$2.74
EPS
-$1.20
Beta
1.64
Shares outstanding
95.65M
No. of employees
3K
News stories
From web sources and news partners
Mahoning Matters
·
8 minutes ago
S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
Cryptonews.net
·
6 minutes ago
S&P 500 price prediction on Black Monday’s 39th anniversary
HDFC Sky
·
45 minutes ago
Nasdaq Jumps 259 Points to 26,399 as Intel Surges 5.5% and AI Stocks Rebound After Brutal Selloff
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2.7K
Founded1991
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websitemyriad.com